Related Experiment Video
Updated: May 15, 2025
06:52
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
10.5K
Probenecid Inhibits NLRP3 Inflammasome Activity and Mitogen-Activated Protein Kinases (MAPKs)
Les P Jones1, David E Martin2, Jackelyn Murray1
1Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA.
Biomolecules
|April 30, 2025
Summary
Probenecid effectively suppresses inflammation by inhibiting NLRP3 inflammasome activation and MAPK signaling pathways in macrophages. This antiviral drug shows promise for treating inflammatory conditions.
Area of Science:
- Pharmacology
- Immunology
- Molecular Biology
Background:
- Probenecid is a versatile drug known for renal transport inhibition and has demonstrated antiviral properties.
- Emerging research highlights probenecid's potential to cross the blood-brain barrier and modulate cellular transporters.
- This study investigates probenecid's anti-inflammatory effects, particularly its impact on inflammasome activation.
Purpose of the Study:
- To investigate the anti-inflammatory effects of probenecid on the NLRP3 inflammasome.
- To elucidate probenecid's impact on mitogen-activated protein kinase (MAPK) signaling pathways.
- To utilize murine macrophages as a model for studying inflammation.
Main Methods:
- Murine macrophages were used to model inflammatory responses.
- Probenecid treatment was administered to assess its effects on cellular signaling.
- Key inflammasome components (NLRP3) and signaling pathways (MAPK, NFκB) were analyzed.
Main Results:
- Probenecid inhibited JNK and ERK signaling pathways but not p38 MAPK.
- NLRP3 inflammasome activation was suppressed by probenecid treatment.
- Probenecid reduced IL-1β release and pyroptosis, key outputs of NLRP3 inflammasome activation.
- NFκB-directed protein expression remained unaffected by probenecid.
Conclusions:
- Probenecid demonstrates significant anti-inflammatory properties by inhibiting NLRP3 inflammasome activation.
- The drug modulates specific MAPK pathways (JNK, ERK) involved in inflammation.
- Probenecid's ability to suppress inflammasome outputs suggests potential therapeutic applications for inflammatory diseases.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
01:31Regulation of the Unfolded Protein Response
2.3K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.3K
01:37The Unfolded Protein Response
4.3K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.3K
01:07MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K